Bacil Pharma

Bacil Pharma

41.10
-2.15
(-4.97%)
hide
Key Fundamentals
Add Ratio
Market Cap
62.10 Cr
EPS
0.64
PE Ratio
53.39
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
62.56
52 Week Low
31.59
PB Ratio
2.29
Debt to Equity
0.01
Forecast For
Actual

Company News

View All News
Caret
neutral
Prakash Bhoorchand Shah Resigns as Director of Bacil Pharma LimitedJul 22, 2025
Prakash Bhoorchand Shah has resigned from his position as Director at Bacil Pharma Limited with immediate effect. In his resignation letter dated July 22, 2025, Shah cited pre-occupation as the reason for his departure. He requested the company to acknowledge receipt of his resignation and submit necessary e-forms with the Registrar of Companies. Shah holds DIN 01136800 and expressed wishes for the company's future growth and prosperity.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
600.00 %
Net Income Growth
-500.00 %
Cash Flow Change
0.40 %
ROE
-132.65 %
ROCE
-132.92 %
EBITDA Margin (Avg.)
-241.36 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
0
0
0
0
0
0
0
0
0
0
1
2
Expenses
0
0
0
0
0
1
0
4
0
0
0
0
EBITDA
0
-0
0
0
-0
-0
-0
-4
-0
-0
0
1
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
1
Tax
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
1
EPS in ₹
-0.05
-0.11
0.00
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.10
0.64
1.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7
7
7
5
5
4
4
1
1
1
26
Fixed Assets
0
5
6
3
3
3
3
0
0
0
0
Current Assets
1
0
0
1
1
0
0
0
0
0
3
Capital Work in Progress
6
0
0
0
0
0
0
0
0
0
0
Investments
0
0
1
1
1
0
0
0
0
1
21
Other Assets
1
1
0
1
1
1
1
1
1
1
4
Total Liabilities
7
7
7
5
5
4
4
1
1
1
26
Current Liabilities
0
0
0
3
3
3
3
0
0
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
Total Equity
7
6
6
2
2
1
1
1
1
1
25
Reserve & Surplus
-0
-0
-0
-4
-5
-5
-5
-5
-5
-5
12
Share Capital
7
7
7
7
7
7
7
7
7
7
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
0
0
0
-0
-0
0
0
-0
0
3
Investing Activities
-0
-0
0
-1
0
0
1
4
-0
0
0
Operating Activities
0
0
0
1
-0
-0
-0
-4
-0
0
0
Financing Activities
0
0
0
0
-0
-0
-0
0
0
-0
2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
20.70 %
10.60 %
0.20 %
0.20 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
51.38 %
53.85 %
53.88 %
52.88 %
52.83 %
52.90 %
53.74 %
53.77 %
53.76 %
53.79 %
53.80 %
53.77 %
53.89 %
53.91 %
59.61 %
67.42 %
75.77 %
77.37 %
Others
5.95 %
3.48 %
3.45 %
4.45 %
4.50 %
4.43 %
3.59 %
3.56 %
3.57 %
3.54 %
3.53 %
3.56 %
3.44 %
3.42 %
19.69 %
21.98 %
24.03 %
22.43 %
No of Share Holders
0
6,410
6,319
6,461
6,514
6,532
6,545
6,548
6,649
6,663
6,647
6,628
6,770
6,794
6,902
7,461
7,638
7,532

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 21.11 27.73
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 35.09 38.72
14 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
14 Nov 2024 37.97 48.04
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2025 46.26 42.55
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 43.70 43.70
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 37.58 37.50
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 35.00 40.37

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Closure of Trading WindowSep 27, 2025
Book Closure For The Purpose Of Annual General MeetingSep 05, 2025
Reg. 34 (1) Annual Report.Sep 05, 2025
Notice Of 38Th Annual General Meeting Of The CompanySep 05, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th September 2025Sep 05, 2025
INTIMATION OF RECEIPT OF REQUEST FOR RECLASSIFICATION OF THE PROMOTER IN ACCORDANCE WITH REGULATION 31A OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015.Sep 04, 2025
Board Meeting Intimation for We Hereby Notify You That A Meeting Of The Board Of Directors Of Bacil Pharma Limited ("The Company") Will Be Held On 05Th September 2025.Sep 02, 2025
Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 27, 2025
Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 25, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August 2025Aug 25, 2025
Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday 25Th August 2025Aug 19, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Results Financial Results For The Quarter Ended 30/06/2025Aug 12, 2025
Board Meeting Outcome for Results For The Quarter Ended 30/06/2025Aug 12, 2025
We Have Recevied Query From BSE Regarding Resignation Of Mr. Prakash B. ShahAug 06, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August2025Aug 05, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Appointment Of Ms. Chaitali Kalpataru Shah As A Executive Director And CFO Of The CompanyJul 16, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 16Th July 2025Jul 16, 2025
Board Meeting Intimation for We Wish To Inform You That The Meeting Of Board Of Directors Scheduled To Be Held On Wednesday 16Th July 2025Jul 11, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 11, 2025
Closure of Trading WindowJun 26, 2025
Receipt Of Listing Approval Granted By Stock Exchange For 8463000 Equity Shares Of Rs.10/- Each Issued At A Premium Of Rs.22/- Issued To Non- Promoter On Preferential BasisJun 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
Revised Audited Financial Result For The Quarter And Year Ended 31St March 2025May 26, 2025
Revised Outcome Of Board Meeting Held On 26Th May 2025 For Audited Financial Result For The Quarter And Year Ended 31St March 2025May 26, 2025
Results-Financial Results For The Year Ended 31/03/2025May 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Audited Financials For The Year Ended 31St March2025May 26, 2025
Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday 26Th May 2025May 17, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 23, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Closure of Trading WindowMar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 25, 2025

Technical Indicators

RSI(14)
Neutral
48.92
ATR(14)
Less Volatile
2.88
STOCH(9,6)
Neutral
32.02
STOCH RSI(14)
Oversold
9.79
MACD(12,26)
Bearish
-0.18
ADX(14)
Weak Trend
15.70
UO(9)
Bearish
60.28
ROC(12)
Downtrend And Accelerating
-4.11
WillR(14)
Neutral
-77.16